In some cancers, such as BC, NF-κB is overexpressed [61]; NF-κB not only is involved in the proliferation and development of BC cells but also leads to resistance to some drugs used in cancer therapy such as anti-epidermal growth factor receptor (EGFR) drugs [62]. This evidence concerns the gene NFKB1 and cancer.